Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer—Results of a false‐negative cytology audit in Polish Cervical Cancer Screening Programme

False‐negative (FN) results in cervical cancer (CC) screening pose significant risk for participants and should be audited. The aim of the study was to analyse the results of audit of FN slides collected in 2010–2013 in Polish Cervical Cancer Screening Program (CCSP) and to seek for risk factors of obtaining true‐negative result (TN; not containing abnormal cells as confirmed in audit) before CC diagnosis.

[1]  P. Fitzpatrick,et al.  Interval cancer audit and disclosure in cervical screening programmes: An international survey , 2021, Journal of medical screening.

[2]  A. Nowakowski,et al.  Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme , 2021, Cancer medicine.

[3]  Lingbo Jiang,et al.  Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs , 2020, BMC Cancer.

[4]  Lingbo Jiang,et al.  Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs , 2020, BMC Cancer.

[5]  Nancy Santesso,et al.  Cytology versus HPV testing for cervical cancer screening in the general population. , 2017, The Cochrane database of systematic reviews.

[6]  A. Nowakowski,et al.  Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening? , 2017, European Journal of Epidemiology.

[7]  S. Monaco,et al.  Bethesda Interobserver Reproducibility Study-2 (BIRST-2): Bethesda System 2014. , 2017, Journal of the American Society of Cytopathology.

[8]  A. Nowakowski,et al.  The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines , 2015, BMC Cancer.

[9]  David C Wilbur,et al.  The Pap Test and Bethesda 2014 , 2015, Acta Cytologica.

[10]  P. Sasieni,et al.  Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers , 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

[11]  H. Adami,et al.  A Longitudinal Swedish Study on Screening for Squamous Cell Carcinoma and Adenocarcinoma: Evidence of Effectiveness and Overtreatment , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  R. Bekkers,et al.  Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  A. Herbert,et al.  European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[14]  Diane Solomon,et al.  The Bethesda interobserver reproducibility study (BIRST) , 2006, Cancer.

[15]  M. Plummer,et al.  Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study , 2003, Cancer Causes & Control.

[16]  B. Hølund,et al.  [False negative Pap smears in a Danish material]. , 2003, Ugeskrift for læger.

[17]  M. Schiffman,et al.  Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. , 2001, JAMA.

[18]  L. Brinton,et al.  Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States) , 2001, Cancer Causes & Control.

[19]  Vic Hasselblad,et al.  Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities , 2000, Annals of Internal Medicine.

[20]  R. Demay.  Cytopathology of false negatives preceding cervical carcinoma. , 1996, American journal of obstetrics and gynecology.

[21]  G. Fleuren,et al.  The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist? , 1996, Acta obstetricia et gynecologica Scandinavica.

[22]  M. Hakama,et al.  The Effect of Mass Screening on Incidence and Mortality of Squamous and Adenocarcinoma of Cervix Uteri , 1995, Obstetrics and gynecology.

[23]  M. Sherman,et al.  High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[24]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[25]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[26]  A. Nowakowski,et al.  Why are Polish women diagnosed with invasive cervical cancer after negative cytology in the organized screening programme - a pilot reevaluation of negative Pap smears preceding diagnoses of interval cancers. , 2021, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[27]  S. Granter,et al.  Uncovering bias in the cytologic evaluation of cervical squamous lesions. , 2015, American journal of clinical pathology.

[28]  Evan R. Myers,et al.  Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review , 2001 .

[29]  W. Frable,et al.  Atypical squamous cells of undetermined significance , 1997, Cancer.